Hua Medicine (Shanghai) Ltd. (HKG:2552)
2.090
+0.030 (1.46%)
May 16, 2025, 4:08 PM HKT
Hua Medicine (Shanghai) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -250.14 | -211.23 | -203.51 | -325.73 | -393.13 | Upgrade
|
Depreciation & Amortization | 33.96 | 35.67 | 31.3 | 30.84 | 18.13 | Upgrade
|
Other Amortization | 0.62 | 0.57 | 0.48 | 0.75 | 0.32 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -0.04 | - | 0.08 | - | Upgrade
|
Stock-Based Compensation | 11.84 | 23.91 | 21.28 | 32.7 | 58.94 | Upgrade
|
Other Operating Activities | -106.25 | -90.5 | -52.53 | 7.56 | 22.49 | Upgrade
|
Change in Accounts Receivable | -23.88 | 372.75 | -413.24 | -13.62 | - | Upgrade
|
Change in Inventory | -82.04 | -42.72 | -1.9 | - | - | Upgrade
|
Change in Accounts Payable | 2.88 | 38.27 | -0.01 | -2.51 | -19.91 | Upgrade
|
Change in Unearned Revenue | - | 756.99 | 366.53 | - | 288.82 | Upgrade
|
Change in Other Net Operating Assets | -4.96 | 5.7 | 21.48 | -3.03 | 3.43 | Upgrade
|
Operating Cash Flow | -417.97 | 889.37 | -230.11 | -272.98 | -20.91 | Upgrade
|
Capital Expenditures | -2.83 | -9.74 | -4.56 | -20.2 | -24.37 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.07 | - | 0.07 | - | Upgrade
|
Cash Acquisitions | - | - | -0.71 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -1.03 | -0.1 | -22.91 | -6.39 | -1.33 | Upgrade
|
Other Investing Activities | 13.9 | 17.85 | 23.42 | -41.71 | 11.61 | Upgrade
|
Investing Cash Flow | 10.04 | 8.08 | -4.75 | -68.22 | -14.09 | Upgrade
|
Long-Term Debt Issued | 133.15 | 200 | 28.92 | - | - | Upgrade
|
Long-Term Debt Repaid | -44.26 | -135.74 | -18.36 | -16.48 | -14.89 | Upgrade
|
Total Debt Repaid | -44.26 | -135.74 | -18.36 | -16.48 | -14.89 | Upgrade
|
Net Debt Issued (Repaid) | 88.89 | 64.26 | 10.56 | -16.48 | -14.89 | Upgrade
|
Issuance of Common Stock | 1.61 | 9.89 | 11 | 10.35 | 7.63 | Upgrade
|
Other Financing Activities | -6.78 | -5.08 | -0.09 | - | - | Upgrade
|
Financing Cash Flow | 83.72 | 69.07 | 21.48 | -6.13 | -7.26 | Upgrade
|
Foreign Exchange Rate Adjustments | 3.13 | 3.68 | 28.78 | -9.52 | -31.26 | Upgrade
|
Net Cash Flow | -321.07 | 970.19 | -184.61 | -356.85 | -73.51 | Upgrade
|
Free Cash Flow | -420.8 | 879.63 | -234.67 | -293.18 | -45.27 | Upgrade
|
Free Cash Flow Margin | -164.44% | 1148.19% | -1333.44% | - | -522.55% | Upgrade
|
Free Cash Flow Per Share | -0.43 | 0.90 | -0.24 | -0.31 | -0.05 | Upgrade
|
Cash Interest Paid | 6.78 | 5.08 | 0.09 | - | - | Upgrade
|
Levered Free Cash Flow | -268.93 | 249.64 | -524.53 | -183.45 | -171.35 | Upgrade
|
Unlevered Free Cash Flow | -263.55 | 254.58 | -522.24 | -180.98 | -168.6 | Upgrade
|
Change in Net Working Capital | 80.92 | -415.56 | 380.88 | 17.63 | 0.06 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.